Search Results - "Krekelä, I"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Undetected coeliac disease in the elderly: a biopsy-proven population-based study by Vilppula, A, Collin, P, Mäki, M, Valve, R, Luostarinen, M, Krekelä, I, Patrikainen, H, Kaukinen, K, Luostarinen, L

    Published in Digestive and liver disease (01-10-2008)
    “…Up to 1% of the population suffer from coeliac disease. Data on the prevalence in elderly people is scant. We hypothesized that they would over time have…”
    Get full text
    Journal Article
  2. 2

    Undetected coeliac disease in the elderly by Vilppula, A, Collin, P, Mäki, M, Valve, R, Luostarinen, M, Krekelä, I, Patrikainen, H, Kaukinen, K, Luostarinen, L

    Published in Digestive and liver disease (2008)
    “…Abstract Background Up to 1% of the population suffer from coeliac disease. Data on the prevalence in elderly people is scant. We hypothesized that they would…”
    Get full text
    Journal Article
  3. 3

    The cleansing result of oral sodium phosphate is inversely correlated with time between the last administration and colonoscopy by Kössi, J, Krekelä, I, Patrikainen, H, Vuorinen, T, Luostarinen, M, Laato, M

    Published in Techniques in coloproctology (01-03-2007)
    “…There is some evidence that the timing of sodium phosphate (NaP) ingestion affects the cleansing result. The objective of this study was to evaluate the…”
    Get full text
    Journal Article
  4. 4

    Gliadin antibodies in older population and neurological and psychiatric disorders by Ruuskanen, A., Kaukinen, K., Collin, P., Krekelä, I., Patrikainen, H., Tillonen, J., Nyrke, T., Laurila, K., Haimila, K., Partanen, J., Valve, R., Mäki, M., Luostarinen, L.

    Published in Acta neurologica Scandinavica (01-01-2013)
    “…Objectives A variety of neurological and psychiatric disorders have recently been linked to coeliac disease and gluten sensitivity. We here explored whether…”
    Get full text
    Journal Article
  5. 5

    Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study by Niemelä, S, Jääskeläinen, T, Lehtola, J, Martikainen, J, Krekelä, I, Sarna, S, Sarelin, H

    “…The efficacy of 50 mg pirenzepine twice daily in the treatment of reflux oesophagitis was compared with that of placebo in 47 patients over a period of 12…”
    Get more information
    Journal Article
  6. 6

    Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study by Lehtola, J, Niemelä, S, Martikainen, J, Krekelä, I

    “…The effect of ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis was studied. A double-blind method was used, and 41 patients with…”
    Get more information
    Journal Article
  7. 7

    Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease by Lantto, E, Järvi, K, Krekelä, I, Lantto, T, Taavitsainen, M, Vedenkangas, H, Vorne, M

    “…The inflammatory activity in 108 bowel segments of 40 patients with suspected or known inflammatory bowel disease was assessed macroscopically by endoscopy,…”
    Get full text
    Journal Article
  8. 8

    Gastric carcinoids with minimal or no macroscopic lesion in patients with pernicious anemia by Lehtola, J, Karttunen, T, Krekelä, I, Niemelä, S, Räsänen, O

    Published in Hepato-gastroenterology (01-04-1985)
    “…In a series of 44 patients with pernicious anemia examined by gastroscopy, three cases of gastric carcinoids were found. During the same ten-year period about…”
    Get more information
    Journal Article
  9. 9